Carvedilol indications and usage: Difference between revisions
Ahmed Zaghw (talk | contribs) No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = COREG (CARVEDILOL) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c57982f2-c7da-488a-7ea9-b9609439ac68#nlm34089-3 | publisher = | date = | accessdate = }}</ref> | ==INDICATIONS AND USAGE== | ||
===Heart Failure=== | |||
COREG® is indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to [[diuretics]], [[ACE inhibitors]], and [[digitalis]], to increase survival and, also, to reduce the risk of hospitalization [see [[Carvedilol drug interactions|Drug Interactions]] and [[Carvedilol clinical studies|Clinical Studies]]]. | |||
===Left Ventricular Dysfunction Following Myocardial Infarction=== | |||
COREG is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a [[myocardial infarction ]]and have a left ventricular [[ejection fraction ]]of ≤40% (with or without symptomatic [[heart failure]]) [see [[Carvedilol clinical studies|Clinical Studies]]]. | |||
===Hypertension=== | |||
COREG is indicated for the management of [[essential hypertension]] [see [[Carvedilol clinical studies|Clinical Studies]]]. It can be used alone or in combination with other antihypertensive agents, especially[[ thiazide]]-type diuretics [see[[Carvedilol drug interactions|Drug Interactions]] ].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = COREG (CARVEDILOL) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c57982f2-c7da-488a-7ea9-b9609439ac68#nlm34089-3 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Revision as of 20:13, 20 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
INDICATIONS AND USAGE
Heart Failure
COREG® is indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization [see Drug Interactions and Clinical Studies].
Left Ventricular Dysfunction Following Myocardial Infarction
COREG is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of ≤40% (with or without symptomatic heart failure) [see Clinical Studies].
Hypertension
COREG is indicated for the management of essential hypertension [see Clinical Studies]. It can be used alone or in combination with other antihypertensive agents, especiallythiazide-type diuretics [seeDrug Interactions ].[1]
References
Adapted from the FDA Package Insert.